Federico Garrido spends much of his time researching Human leukocyte antigen, Immunology, MHC class I, Major histocompatibility complex and Antigen. His studies deal with areas such as Tumor Escape, Cytotoxic T cell, Molecular biology, Melanoma and Loss of heterozygosity as well as Human leukocyte antigen. Federico Garrido combines subjects such as Cancer, Cancer research and Downregulation and upregulation with his study of Immunology.
His Cancer research study incorporates themes from Phenotype and Pathology. Federico Garrido has included themes like Cell and MHC class II in his MHC class I study. In his research, Gene expression is intimately related to Immunohistochemistry, which falls under the overarching field of Antigen.
Human leukocyte antigen, Immunology, Antigen, Molecular biology and MHC class I are his primary areas of study. His Human leukocyte antigen research is multidisciplinary, incorporating elements of Cancer, Immunotherapy, Cancer research, Loss of heterozygosity and Major histocompatibility complex. His Immunology research includes themes of Phenotype and Cytotoxic T cell.
His research in Antigen tackles topics such as Monoclonal antibody which are related to areas like Immunohistochemistry. Federico Garrido interconnects Cell culture, Cell, Gene expression, Gene and In vivo in the investigation of issues within Molecular biology. The concepts of his MHC class I study are interwoven with issues in Cancer cell, Fibrosarcoma and Clone.
Federico Garrido mostly deals with Human leukocyte antigen, Cancer research, Immune system, Immunology and Immunotherapy. Human leukocyte antigen is the subject of his research, which falls under Antigen. His biological study spans a wide range of topics, including Bladder cancer, Cytotoxic T cell, MHC class I, Major histocompatibility complex and Disease.
The various areas that Federico Garrido examines in his Immune system study include Cancer, Tumor progression and Cancer dormancy. His study in Immunology is interdisciplinary in nature, drawing from both Viral vector and Gene. His work in the fields of Immunotherapy, such as Cancer immunotherapy, overlaps with other areas such as Context.
His primary areas of investigation include Human leukocyte antigen, Immunology, Immune system, MHC class I and Immunotherapy. His research in Human leukocyte antigen intersects with topics in T cell, Antigen presentation, Cancer immunotherapy, Melanoma and Loss of heterozygosity. Federico Garrido has researched Immunology in several fields, including Cancer and Cytotoxic T cell.
His Immune system research incorporates themes from Stromal cell and Infiltration. MHC class I is a subfield of Major histocompatibility complex that Federico Garrido tackles. His studies in Immunotherapy integrate themes in fields like Immunohistochemistry, Urinary bladder and MHC class I antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS
Federico Garrido;Francisco Ruiz-Cabello;Teresa Cabrera;Juan J. Pérez-Villar.
Immunology Today (1997)
Natural history of HLA expression during tumour development
Federico Garrido;Teresa Cabrera;Angel Concha;Susan Glew.
Immunology Today (1993)
MHC class I antigens, immune surveillance, and tumor immune escape.
Angel Garcia-Lora;Ignacio Algarra;Federico Garrido.
Journal of Cellular Physiology (2003)
MHC antigens and tumor escape from immune surveillance.
Federico Garrido;Ignacio Algarra.
Advances in Cancer Research (2001)
The urgent need to recover MHC class I in cancers for effective immunotherapy.
Federico Garrido;Natalia Aptsiauri;Elien M Doorduijn;Angel M Garcia Lora.
Current Opinion in Immunology (2016)
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Ignacio Algarra;Angel García-Lora;Teresa Cabrera;Francisco Ruiz-Cabello.
Cancer Immunology, Immunotherapy (2004)
HLA class I antigen abnormalities and immune escape by malignant cells.
Barbara Seliger;Teresa Cabrera;Federico Garrido;Soldano Ferrone.
Seminars in Cancer Biology (2002)
"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.
Federico Garrido;Teresa Cabrera;Natalia Aptsiauri.
International Journal of Cancer (2010)
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.
Alfonso Serrano;Silvia Tanzarella;Ilaria Lionello;Rosa Mendez.
International Journal of Cancer (2001)
A new extract of the plant calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation
Eva Jiménez-Medina;Angel Garcia-Lora;Laura Paco;Ignacio Algarra.
BMC Cancer (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: